Solutions from Harvard Bioscience are more than instruments. With exceptional service, we are partners in the quest for knowledge and discovery. Showcasing our BUXCO and FinePointe Inhalation and Respiratory portfolio, we give researchers the confidence to conduct reliable, reproducible research, from initial exposure through pulmonary assessment. Visit our website (harvardbioscience.com) and meet us at booth #528 to explore how cutting-edge technology advances your research. From in vitro to in vivo, we have you covered.
CVS Specialty
CVS Specialty® is the largest specialty pharmacy in the U.S., serving patients with complex and chronic conditions. Patients are supported by dedicated care teams of pharmacists, nurses, and skilled clinicians who specialize in specific conditions. We prioritize communication with healthcare providers to streamline the prescribing process and focus on personalized patient communication and support, to help ensure that patients successfully begin and continue their therapy.
Bayer
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds, which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated. | Bayer is a global life sciences leader in healthcare and nutrition. Building on a 150-year legacy in healthcare. Bayer is committed to improving patient lives by developing therapies and delivering first-in-class educational and support programs to meet their needs | Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing aging population. Bayer is committed to the principles of sustaining development, and the Bayer brand stands for trust, reliability, and quality throughout the world. See Bayer’s Privacy Statement at https://www.bayer.com/en/privacy-statement. | Bayer is a global life sciences leader in healthcare & nutrition. Building on a 150-yr legacy in healthcare, Bayer is committed to improving patient lives by developing therapies & delivering 1st-in-class educational & support programs to meet needs. | Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing aging population. Bayer is committed to the principles of sustaining development, and the Bayer brand stands for trust, reliability, and quality throughout the world. Bayer Medical Information: https://askmed.bayer.comPrivacy Statement: https://labeling.bayerhealthcare.com/html/privacy.htm | Building on a century of expertise, Bayer Radiology is committed to advancing radiology, guided daily by our purpose—everyone deserves clear answers about their health. With a passionate team and a presence in more than 140 countries, Bayer is a global leader in medical imaging. Our mission is to shape the patient experience, beginning with diagnostic care, to help improve patient outcomes. Bayer Radiology’s leading radiology portfolio features contrast agents and devices for precise administration across modalities including computed tomography (CT), X-ray and magnetic resonance (MR), and positron emission tomography (PET). The portfolio is complemented by an end-to-end diagnostic support ecosystem that includes power injection systems with sterile disposables, 24/7 equipment service, enterprise informatics, and clinical support. Fully committed to the ongoing advancement of medical imaging, Bayer Radiology continues to pioneer solutions that will help health care teams answer critical questions about the diagnosis and monitoring of serious diseases—because everyone deserves clear answers about their health.
Alveolar Capillary Dysplasia Association (ACDA)
Alveolar Capillary Dysplasia with misalignment of the pulmonary veins (ACDMPV) results in an infant fatality in almost every occurrence due to the inability of the lungs to effectively deliver oxygen to the bloodstream. The ACDA is dedicated to increasing ACDMPV awareness and funding ACDMPV research in the medical community. Searching For Answers…Hoping for a Cure.
4DMedical
4DMedical is a global leader in innovative respiratory and cardiopulmonary imaging software. Our SaaS solutions deliver non-invasive, regional, and lobar quantitative lung function analysis—giving pulmonologists and clinicians the power to act sooner and with objective data for patients with unexplained dyspnea, asthma, COPD, and other lung diseases. We also support early intervention with low-dose lung health screenings and physician-customized smoking cessation tools to help prevent disease progression. 4DMedical’s CT:VQ™ is the world’s first and only non-contrast post-processing technology that transforms routine chest CT scans into detailed, quantitative maps of lung ventilation (V) and perfusion (Q), all without injected contrast or radioisotopes. CT:VQ™ seamlessly fits into your existing workflow, delivering results directly for rapid interpretation—all from the CT you already order. You can act sooner with objective perfusion data—from the CT you already order. Enhance patient care with actionable functional data from every chest CT—accelerating your path from suspicion to confident clinical decision. | 4DMedical is a global leader in innovative respiratory and cardiopulmonary imaging software. Using advanced, non-invasive CT imaging technology, our SaaS offerings provide non-invasive, regional and lobar quantitative lung function analysis for unparalleled insights into cardiopulmonary health. With a single CT lung scan, 4DMedical provides automated, quantitative analysis that equips radiologists with detailed insights to support ordering physicians in delivering optimal patient care. Now available: CT:VQ™ is the world’s first and only non-contrast post-processing technology that transforms routine chest CT scans into quantitative, lobar ventilation (V) and perfusion (Q) maps—without contrast media, inhaled agents, or added scan time. Results are automatically delivered to PACS, ready for radiologist interpretation alongside the source CT images. For Radiologists: – One modality, one department: Complete pulmonary imaging with no new hardware or workflow steps – Add objective, functional metrics to every routine CT – Improve reporting consistency and inter-reader reproducibility – Automated, quantitative reporting and seamless PACS integration – Peer-reviewed, proven correlation with spirometry and radiologist-based metrics – Enhance your CT utility—structure and function, together in a single exam With 4DMedical, radiologists can deliver both structural and functional lung, and cardiac assessment from standard CT, enhancing diagnostic confidence, improving report value, and streamlining workflow efficiency.